Serge Saxonov, 10x Genomics CEO
August 29, 2023 04:05 PM EDT
R&D

Ex­clu­sive: 10x Ge­nomics CEO touts ‘in­cred­i­ble trac­tion’ with newest launch, ship­ping over 100 spa­tial bi­ol­o­gy an­a­lyz­ers

Andrew Dunn

Senior Biopharma Correspondent

10x Ge­nomics has seen “in­cred­i­ble trac­tion” with its newest prod­uct, Xe­ni­um, ship­ping over 100 an­a­lyz­ers since launch­ing less than a year ago, CEO Serge Sax­onov …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times